{"id":32856,"date":"2020-08-10T10:04:46","date_gmt":"2020-08-10T09:04:46","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=32856"},"modified":"2021-03-19T09:09:42","modified_gmt":"2021-03-19T09:09:42","slug":"gut-brain-axis-2018-speakers","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/","title":{"rendered":"Gut-Brain Axis 2018 Speakers"},"content":{"rendered":"
\n

\n\tOur
Speakers (A-Z)
\n\t<\/h2>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32878″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/birgitte-holst\/birgitte_holst_university_copenhagen_biotech_pharma_summit_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"1"}” data-image-title=”Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Birgitte_Holst_University_Copenhagen_BioTech_Pharma_Summit_2-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tBirgitte Holst\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor MSO in Metabolic and Molecular Pharmacology, Founder and Head of Rodent Metabolic Phenotyping Center and Group leader of the Novo Nordisk Foundation Center for Basic Metabolic Research.<\/h5>\n

\n\t\t\t\n\tNeurotensin \u2013 An Overlooked Gut-Hormone Regulating Appetite\n\t\t\t<\/a>\n\t<\/h3>\n\t

For the last more than 10 years, Prof. Birgitte Holst group has been working with the molecular pharmacology of G-protein coupled receptor involved in endocrine regulation. Most focus has been on Gut hormone receptors and its signalling properties such as biased signalling and constitutive activity and how these properties translate into in vivo functions for metabolic diseases.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32883″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/bruno-bonaz\/bruno_bonaz_biotech_pharma_summit_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"2.8","credit":"","camera":"DMC-FZ38","caption":"","created_timestamp":"1446484058","copyright":"","focal_length":"4.8","iso":"200","shutter_speed":"0.033333333333333","title":"","orientation":"1"}” data-image-title=”Bruno_Bonaz_BioTech_Pharma_Summit_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Bruno_Bonaz_BioTech_Pharma_Summit_2-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tBruno Bonaz\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor of Gastroenterology in the Grenoble Faculty of Medicine and Hospital in France<\/h5>\n

\n\t\t\t\n\tThe Vagus Nerve and its Inflammatory Role in the (Microbiota)-Brain-Gut Axis\n\t\t\t<\/a>\n\t<\/h3>\n\t

Bruno Bonaz is a Professor of Gastroenterology in the Grenoble Faculty of Medicine and Hospital in France. He is a member of the team \u201cCerebral Stimulation & Systems Neuroscience\u201d (team leader: Olivier David) at the Grenoble Institute of Neurosciences, and was previously the team leader of the group Stress and Neurodigestive Interactions at the GIN.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2-201×300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2-686×1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2-768×1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2-630×940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2-420×627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2-315×470.png 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32914″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/christopher-reyes\/christopher_reyes_bloom_science_biotech_pharma_summit_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2.png” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}” data-image-title=”Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2-201×300.png” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Christopher_Reyes_Bloom_Science_Biotech_Pharma_Summit_2-686×1024.png”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tChristopher Reyes\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Co-founder and CSO, Bloom Science<\/h5>\n

\n\t\t\t\n\tHarnessing the Therapeutic Potential of Commensal Microbes for the Treatment for Human Epilepsy\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Christopher Reyes is Chief Scientific Officer and co-founder at Bloom Science (www.bloomscience.co<\/a>), a biotechnology company focused on dramatically improving the lives of patients. Connecting the gut microbiota to diet, metabolism, neural activity and behavior, we are developing effective microbe-based therapeutics to make measurable improvements to outcomes that matter to patients.<\/p>\n\t\t\t\t\t\t\t\"\"\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32909″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/david-finkelstein\/david_finkelstein_florey_institute_neuroscience_mental_health_biotech_pharma_summit_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"6.3","credit":"MC","camera":"Canon EOS-1Ds Mark III","caption":"","created_timestamp":"1414666039","copyright":"","focal_length":"160","iso":"125","shutter_speed":"0.005","title":"","orientation":"1"}” data-image-title=”David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/David_Finkelstein_Florey_Institute_Neuroscience_Mental_Health_Biotech_Pharma_Summit_2-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tDavid Finkelstein\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Assoc. Professor, Head, Parkinson\u2019s Disease Laboratory, Florey Institute of Neuroscience and Mental Health at University of Melbourne<\/h5>\n

\n\t\t\t\n\tDeveloping Therapeutics for the Gastrointestinal Problems in Parkinsons Disease\n\t\t\t<\/a>\n\t<\/h3>\n\t

Since graduating with a PhD in Physiology, have worked to translate knowledge from fundamental science projects to provide clinical applications. Initially the research interests were centred on the physiology of control of movement, age related neurodegeneration and regeneration. Have subsequently used this basic science knowledge and applied it into developing novel therapeutic avenues for the treatment of Parkinson\u2019s disease and Parkinsonism.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2-201×300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2-686×1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2-768×1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2-630×940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2-420×627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2-315×470.png 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32947″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/george-weinstock\/george_weinstock_biotech_pharma_summit_profile_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2.png” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}” data-image-title=”George_Weinstock_BioTech_Pharma_Summit_Profile_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2-201×300.png” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/George_Weinstock_BioTech_Pharma_Summit_Profile_2-686×1024.png”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeorge Weinstock\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Director of Microbial Genomics at Jackson Laboratory<\/h5>\n

\n\t\t\t\n\tMicrobiome Past, Present, and Future\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. George Weinstock is the Evnin Family Professor and Director of Microbial Genomics at the Jackson Laboratory for Genomic Medicine where he established a group devoted to genomic studies of infectious diseases and the human microbiome. The group collaborates extensively with clinicians to apply genomic analyses to a wide range of medical problems.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2-201×300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2-686×1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2-768×1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2-630×940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2-420×627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2-315×470.png 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32919″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/koen-venema\/koen_venema_biotech_pharma_summit_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2.png” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}” data-image-title=”Koen_Venema_BioTech_Pharma_Summit_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2-201×300.png” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Koen_Venema_BioTech_Pharma_Summit_2-686×1024.png”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tKoen Venema\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Founder & CEO of Beneficial Microbes Consultancy and Chair in Gut Microbiology at Maastricht University<\/h5>\n

\n\t\t\t\n\tEffects of Foods and Drugs on SCFA Production by the Gut Microbiota and How this Relates to the Gut-Brain Axis\n\t\t\t<\/a>\n\t<\/h3>\n\t

Prof. Dr. Koen Venema is i) Professor at University Maastricht \u2013 campus Venlo, ii) founder and CEO of the company Beneficial Microbes Consultancy, iii) the initiator and co-organizer of the Beneficial Microbe Conference-series, and iv) editor-in-chief of Beneficial Microbes.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2-201×300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2-686×1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2-768×1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2-630×940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2-420×627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2-315×470.png 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32931″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/marion-soto\/marion_soto_lnc_therapeutics_biotech_pharma_summit_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2.png” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}” data-image-title=”Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2-201×300.png” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Marion_Soto_LNC_Therapeutics_BioTech_Pharma_Summit_2-686×1024.png”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tMarion Soto\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Project leader, LNC Therapeutics<\/h5>\n

\n\t\t\t\n\tInteractions Between Gut Microbiota and Brain in Metabolic Diseases\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Marion Soto is leader of a project targeting the gut-brain axis at LNC Therapeutics. After graduating from the Ecole Polytechnique in Paris, she earned a Ph.D. in Nutrition and Neurobiology in 2014 from AgroParisTech in France. Marion was then a fellow in C. Ronald Kahn Laboratory at Joslin Diabetes Center, Harvard Medical School.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32904″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/martha-g-welch\/martha_welch_biotech_pharma_summit_profile_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"1"}” data-image-title=”Martha_Welch_BioTech_Pharma_Summit_Profile_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Martha_Welch_BioTech_Pharma_Summit_Profile_2-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tMartha G. Welch\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Director of the Nurture Science Program at Columbia University Medical Center<\/h5>\n

\n\t\t\t\n\tIt\u2019s All About Nurture: Gut-Brain Peptides, Inflammation, and Emotional and Behavioral Disorders\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Martha Welch is Director of the Nurture Science Program in Pediatrics at Columbia University Medical Center. A neuroscientist and clinician with 40+ years of experience working with children with developmental disorders. Dr. Welch is Associate Professor of Psychiatry in Pediatrics and Pathology & Cell Biology.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32899″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/nikolaos_venizelos_orebro_university_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"1"}” data-image-title=”Nikolaos_Venizelos_Orebro_University_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tNikolaos Venizelos\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor emeritus and Head of the Neuropsychiatric Research Laboratory & Biobank, Nutrition-Gut-Brain Interactions Research Centre (NGBI), School of Medical Sciences at \u00d6rebro University<\/h5>\n

\n\t\t\t\n\tProinflammatory Cytokines and Oxidative Stress Can Cause Cognitive Dysfunction in Schizo- phrenia, Bipolar Disorders, and Related CNS Diseases\n\t\t\t<\/a>\n\t<\/h3>\n\t

Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry & physiology at the Karolinska Institutet, he obtained a professional certification\/license as a specialist in Clinical Chemistry from the Ministry of Health in Greece.<\/p>\n

2016, Prof. Venizelos was awarded with the \u201cDelphic Prize for Outstanding Contributions to Psychiatry and Related Sciences<\/i>\u201d, and from 2017 he serves as Ambassador of the World Congresses of Biological Psychiatry.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2-201×300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2-686×1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2-768×1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2-630×940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2-420×627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2-315×470.png 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32937″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/patrice-garnier\/patrice_garnier_biotech_pharma_summit_amabiotics_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2.png” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}” data-image-title=”Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2-201×300.png” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Patrice_Garnier_BioTech_Pharma_Summit_Amabiotics_2-686×1024.png”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tPatrice Garnier\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
CEO at Amabiotics<\/h5>\n

\n\t\t\t\n\tFrom Microbiome Explorations to Effective Innovative Therapies in Parkinson Disease: a case study\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Patrice Garnier is Chief Executive Officer for Amabiotics (www.amabiotics.com<\/a>), a biopharmaceutical company that develops innovative diagnostics and microbiome- derived medicines to fight age-related diseases with a strong research focuses on gut-brain axis pathologies, metabolic disorders and oncology. The leading drug candidate, AMA-101, is a potential first-in- class therapy for Parkinson\u2019s disease.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2-201×300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2-686×1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2-768×1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2-630×940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2-420×627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2-315×470.png 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32942″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/philip-strandwitz\/philip_strandwitz_holobiome_biotech_pharma_summit_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2.png” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}” data-image-title=”Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2-201×300.png” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Philip_Strandwitz_Holobiome_BioTech_Pharma_Summit_2-686×1024.png”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tPhilip Strandwitz\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Co-Founder and CEO, Holobiome<\/h5>\n

\n\t\t\t\n\tNeurotransmission and the Human Gut Microbiota\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Philip Strandwitz is a specialist in the microbiome, with a focus on the gut-brain-axis. Philip received his PhD in Biology under the guidance of Dr. Kim Lewis at Northeastern University, where he focused on cultivating unique bacteria from the human gut microbiota, as well as studying their ability to modulate neurotransmitters.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32926″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/robert-brummer\/robert_brummer_biotech_pharma_summit_orebro_university_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"1"}” data-image-title=”Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Robert_Brummer_BioTech_Pharma_Summit_Orebro_University_2-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tRobert Brummer\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor of Gastroenterology and Clinical Nutrition, Director Nutrition-Gut-Brain Interactions Research Centre, Pro-Vice-Chancellor International, External Relations and Innovation at \u00d6rebro University.<\/h5>\n

\n\t\t\t\n\tKnowledge and knowledge Gaps in GBA\n\t\t\t<\/a>\n\t<\/h3>\n\t

Robert Brummer studied medicine at Nijmegen University, The Netherlands. After obtaining his MD in 1983 he was appointed as resident physician at the Department of Clinical Nutrition, G\u00f6teborg University and University Hospital, Sweden and started his PhD studies. Subsequently, he continued clinical training at the Department of Medicine, Maastricht, The Netherlands and was registered as senior consultant in Internal medicine as well as Gastroenterology and Hepatology.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32007″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/rochellys-diaz-heijtz\/rochellys_diaz_heijtz_karolinska-institutet_biotech_pharma_summit_profile\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"1"}” data-image-title=”Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile” data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tRochellys Diaz Heijtz\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet<\/h5>\n

\n\t\t\t\n\tGut Microbes and the Developing Brain\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet. Her research studies have a long-term goal of understanding the biological basis of neurodevelopmental disorders (ASD, ADHD), and how genes and the environment (prenatal and\/or early postnatal) together influence typical and atypical brain development and behavior.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32866″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/ruth-ann-luna\/ruth_ann_luna_metagenomics_texas_children_microbiome_center_biotech_pharma_summit_profile\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"1466847788","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"1"}” data-image-title=”Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile” data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ruth_Ann_Luna_Metagenomics_Texas_Children_Microbiome_Center_BioTech_Pharma_Summit_profile-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tRuth Ann Luna\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Assistant Professor in the Department of Pathology & Immunology at Baylor College of Medicine (BCM) and Director of Medical Metagenomics in the Texas Children\u2019s Microbiome Center (TCMC) at Texas Children\u2019s Hospital<\/h5>\n

\n\t\t\t\n\tMulti-omic Characterization of the Microbiome-Gut-Brain Axis in Autism Spectrum Disorder\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Ruth Ann Luna serves as Assistant Professor in the Department of Pathology & Immunology at Baylor College of Medicine (BCM) and Director of Medical Metagenomics in the Texas Children\u2019s Microbiome Center (TCMC) at Texas Children\u2019s Hospital. She also serves as director of the Clinical Metagenomics Fellowship as well as a member of the Institutional Review Board at BCM.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32894″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/sarkis-k-mazmanian\/sarkis_mazmanian_biotech_pharma_summit_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"1.4","credit":"Getty Images","camera":"Canon EOS-1D Mark III","caption":"PASADENA, CA – SEPTEMBER 16: Micro biologist Sarkis Mazmanian, an expert in human health and disease, is seen during an interview and video taping by Home Front Communications for the MacArthur Foundation at the California Institute of Technology (Caltech) in Pasadena, California. (Photo by David McNew\/Getty Images)","created_timestamp":"1347798044","copyright":"2012 Getty Images","focal_length":"50","iso":"400","shutter_speed":"0.008","title":"","orientation":"1"}” data-image-title=”Sarkis_Mazmanian_BioTech_Pharma_Summit_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Sarkis_Mazmanian_BioTech_Pharma_Summit_2-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tSarkis K. Mazmanian\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Calltech and Co-Founder Axial Biotherapeutics<\/h5>\n

\n\t\t\t\n\tFecal Microbiota Transplants (FMTs) Have Shown Great Clinical Success in Recurrent C. difficile Infections. May This Approach Have Efficacy in Regulating the Gut-Brain Axis?\n\t\t\t<\/a>\n\t<\/h3>\n\t

Sarkis K. Mazmanian, PhD, is the Luis & Nelly Soux Professor of Microbiology in the Division of Biology & Biological Engineering at the California Institute of Technology (Caltech), and an Investigator of the Heritage Medical Research Institute. He was a Phi Beta Kappa graduate from the University of California, Los Angeles, where Dr. Mazmanian also received his PhD training in microbiology and immunology.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit-201×300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit-686×1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit-768×1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit-630×940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit-420×627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit-315×470.png 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32049″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/serguei-fetissov\/serguei_fetissov_rouen_university_biotech_pharma_summit\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit.png” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}” data-image-title=”Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit” data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit-201×300.png” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Serguei_Fetissov_Rouen_University_BioTech_Pharma_Summit-686×1024.png”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tSergue\u00ef O. Fetissov\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor of physiology at Rouen University and co-founder of TargEDys.<\/h5>\n

\n\t\t\t\n\tGut Microbiota and Host Motivated Behavior\n\t\t\t<\/a>\n\t<\/h3>\n\t

Serguei Fetissov MD, PhD, was graduated from Military Medical Academy in St Petersburg and received his PhD from Institute of Developmental Biology of Russian Academy of Science in Moscow combined with training in Pierre & Marie Curie University in Paris. He worked as a researcher and principle investigator for more than 20 years in the field of physiology, neuroscience and nutrition in academic institutions including College de France in Paris, Upstate Medical University in Syracuse, USA and Karolinska Institutet in Stockholm, Sweden.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2-315×470.jpg 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32888″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/ted-dinan\/ted_dinan_biotech_pharma_summit_apc_microbiome_institute_2\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2.jpg” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"1.7","credit":"","camera":"SM-G935F","caption":"","created_timestamp":"1495471536","copyright":"","focal_length":"4.2","iso":"125","shutter_speed":"0.02","title":"","orientation":"1"}” data-image-title=”Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2″ data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2-201×300.jpg” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Ted_Dinan_BioTech_Pharma_Summit_APC_Microbiome_Institute_2-686×1024.jpg”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tTed Dinan\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor of Psychiatry and a Principal Investigator in the APC Microbiome Institute at University College Cork<\/h5>\n

\n\t\t\t\n\tBrain-Gut-Microbiota Axis: A Target for Stress Related Disorders\n\t\t\t<\/a>\n\t<\/h3>\n\t

Ted Dinan is Professor of Psychiatry and a Principal Investigator in the APC Microbiome Institute at University College Cork. He was previously Chair of Clinical Neurosciences and Professor of Psychological Medicine at St. Bartholomew\u2019s Hospital, London. Prior to that, he was a Senior Lecturer in Psychiatry at Trinity College Dublin.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile-201×300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile-686×1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile-768×1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile-630×940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile-420×627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile-315×470.png 315w” sizes=”(max-width: 820px) 100vw, 820px” data-attachment-id=”32012″ data-permalink=”https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/wouter-de-jonge\/de_jonge-wouter_gut_week_biotech_pharma_summit_amc_amsterdam_microbiome_3_profile\/” data-orig-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile.png” data-orig-size=”820,1224″ data-comments-opened=”1″ data-image-meta=”{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}” data-image-title=”De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile” data-image-description=”” data-medium-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile-201×300.png” data-large-file=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/De_Jonge-Wouter_Gut_Week_BioTech_Pharma_Summit_AMC_Amsterdam_Microbiome_3_profile-686×1024.png”>\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tWouter de Jonge\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor of Neurogastroenterology at AMC, CoFounder of Gut Research<\/h5>\n

\n\t\t\t\n\tBioelectronic Medicine: Principle and Feasibility\n\t\t\t<\/a>\n\t<\/h3>\n\t

Professor Wouter de Jonge received his doctoral training at University of Utrecht, and Columbia University, and received his Phd in 2001 (Medicine, University of Amsterdam and Maastricht). He took up postdoctoral positions at the AMC in Amsterdam (prof Guy Boeckxstaens) and Oxford University (prof Siamon Gordon). He chairs the gastro-intestinal research group (www.gut-research.com) at the AMC since 2013 and holds a part time W2 professorship at the Dept of Surgery at the University of Bonn, Germany.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Our Speakers (A-Z) Bruno Bonaz Professor of Gastroenterology in the Grenoble Faculty of Medicine and Hospital in France The Vagus Nerve and its Inflammatory Role in the (Microbiota)-Brain-Gut Axis Bruno Bonaz is a Professor of Gastroenterology in the Grenoble Faculty of Medicine and Hospital in France. He is a member of the team \u201cCerebral Stimulation…<\/p>\n","protected":false},"author":1,"featured_media":31776,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-32856","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nGut-Brain Axis 2018 Speakers • BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year\u2019s event brings together leading scientists, physicians, and senior leaders\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gut-Brain Axis 2018 Speakers • BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year\u2019s event brings together leading scientists, physicians, and senior leaders\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-19T09:09:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/06\/gut_Brain_Axis_BioTech_Pharma_Summit_New_Paris.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1152\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"13 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/\",\"name\":\"Gut-Brain Axis 2018 Speakers • BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/06\/gut_Brain_Axis_BioTech_Pharma_Summit_New_Paris.png\",\"datePublished\":\"2020-08-10T09:04:46+00:00\",\"dateModified\":\"2021-03-19T09:09:42+00:00\",\"description\":\"On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year\u2019s event brings together leading scientists, physicians, and senior leaders\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/06\/gut_Brain_Axis_BioTech_Pharma_Summit_New_Paris.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/06\/gut_Brain_Axis_BioTech_Pharma_Summit_New_Paris.png\",\"width\":1920,\"height\":1152},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gut-Brain Axis 2018 Speakers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow's healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gut-Brain Axis 2018 Speakers • BioTech Pharma Summit","description":"On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year\u2019s event brings together leading scientists, physicians, and senior leaders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/","og_locale":"en_US","og_type":"article","og_title":"Gut-Brain Axis 2018 Speakers • BioTech Pharma Summit","og_description":"On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year\u2019s event brings together leading scientists, physicians, and senior leaders","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-03-19T09:09:42+00:00","og_image":[{"width":1920,"height":1152,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/06\/gut_Brain_Axis_BioTech_Pharma_Summit_New_Paris.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/","name":"Gut-Brain Axis 2018 Speakers • BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/06\/gut_Brain_Axis_BioTech_Pharma_Summit_New_Paris.png","datePublished":"2020-08-10T09:04:46+00:00","dateModified":"2021-03-19T09:09:42+00:00","description":"On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year\u2019s event brings together leading scientists, physicians, and senior leaders","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/06\/gut_Brain_Axis_BioTech_Pharma_Summit_New_Paris.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/06\/gut_Brain_Axis_BioTech_Pharma_Summit_New_Paris.png","width":1920,"height":1152},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Gut-Brain Axis 2018 Speakers"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow's healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=32856"}],"version-history":[{"count":4,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32856\/revisions"}],"predecessor-version":[{"id":36122,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32856\/revisions\/36122"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/31776"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=32856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}